用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [药品] 包含 'Ezetimibe '
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页401 条记录, 当前第1/41页。
公开号 公开日 申请号 申请日
1. CN103585157A 2014/2/19 CN20131567999 2013/11/13
专利标题:A kind of double-layer tablet containing ezetimibe and rosuvastatin and preparation method thereof 法律状态
专利权人


2. WO2014025927A1 2014/2/13 WO2013US54011 2013/8/7
专利标题:METHOD OF PRODUCING CHIRAL N-SUBSTITUTED ALLYLIC AMINE COMPOUNDS 法律状态
The method relates to the field of asymmetric allylic amination and comprises preparing a chiral N-substituted allylic amine compound from the corresponding allylic substrates and substituted hydroxylamines, in the presence of a catalyst, said catalyst comprising copper compounds and a chiral ligand. Examples of chiral amine compounds which can be made using the method include Vigabatrin, Ezetimibe Terbinafme, Naftifme 3-methylmorphine, Sertraline, Cinacalcet, Mefloquine hydrochloride, and Rivas...


3. CN103570574A 2014/2/12 CN20121253879 2012/7/20
专利标题:Intermediate used in a kind of synthetic method of ezetimibe and the method 法律状态
专利权人


4. WO2014012372A1 2014/1/23 WO2013CN71092 2013/1/29
专利标题:PROCESS FOR SYNTHESIS OF EZETIMIBE AND INTERMEDIATES USED IN SAID PROCESS 法律状态
A process for the production of ezetimibe and intermediates used in said process are disclosed. A kind of Morita-Baylis-Hillman adduct can be altered to carboxylic acid derivatives of beta-arylamino alpha-methylene with high activity and selectivity by means of ally lamination reaction, and the above carboxylic acid derivatives of beta-arylamino alpha-methylene can be altered to the chiral intermediates of ezetimibe by means of simple conversion and further synthesized into the chiral drug ezeti...


5. CN102746249B 2013/12/25 CN20121233499 2012/7/7
专利标题:Purification refining method of ezetimibe intermediate 法律状态


6. CN102531985B 2013/12/18 CN20111103365 2011/4/25
专利标题:Method for preparing ezetimibe key intermediate 法律状态


7. CN103450065A 2013/12/18 CN20131296900 2013/7/15
专利标题:Preparation method of ezetimibe 法律状态


8. CN103435525A 2013/12/11 CN20131319745 2013/7/25
专利标题:Preparation method of ezetimibe 法律状态


9. CN103417972A 2013/12/4 CN20131367116 2013/8/13
专利标题:Cholesterol uptake inhibitor and vitamin-B composition and application thereof 法律状态
专利权人SHENZHEN AUSA PHARMED LTD;


10. EP2231118B1 2013/12/4 EP20080861465 2008/12/17
专利标题:Suspension comprising non-micronized ezetimibe micro-particles 法律状态



首页123456下页尾页401 条记录, 当前第1/41页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文